Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Incidence and Outcomes for Low Risk Myelodysplastic Syndrome: A Surveillance, Epidemiology and End Results (SEER) Study

Yue Zhang, MD, MPH, Nikolai A. Podoltsev, MD, PhD, Bonnie E. Gould Rothberg, MD, PhD, MPH, Madhav V. Dhodapkar, MD, Daniel Morgensztern, MD

Blood (2012) 120 (21): 4944.

https://doi.org/10.1182/blood.V120.21.4944.4944

Published: 2012

Journal Articles

Waldenstrom's Macroglobulinemia: A SEER Database Review From 1981-2005.

Jeevan Sekhar, Daniel Morgensztern, Qin Zhang, MS, Ravi Vij, MBBS

Blood (2009) 114 (22): 2926.

https://doi.org/10.1182/blood.V114.22.2926.2926

Published: 2009

Journal Articles

High Remission Rates and Prolonged Progression Free Survival in Newly Diagnosed Patients with Mantle Cell Lymphoma Treated with R-MACLOIVAM-T

Peter J Hosein, MD, Daniel Morgensztern, MD, Francine Coleman, MPH, Gail Walker, PhD, Maricer Escalon, MD, Joseph Rosenblatt, MD, Izidore S Lossos, MD

Blood (2008) 112 (11): 3597.

https://doi.org/10.1182/blood.V112.11.3597.3597

Published: 2008

Journal Articles

Lack of Survival Improvement in Patients with Large Cell Lymphomas of T-Cell Phenotype: A SEER Analysis Comparing Outcomes According to Phenotype and Year of Diagnosis.

Daniel Morgensztern, MD, Gail Walker, PhD., Leonidas Koniaris, M.D., Izidore S. Lossos, M.D.

Blood (2007) 110 (11): 3577.

https://doi.org/10.1182/blood.V110.11.3577.3577

Published: 2007

Journal Articles

Primary Non-Hodgkin’s Lymphoma of the Lung.

Thomas Fong, MD, Izidore Lossos, M.D., Daniel Morgensztern, M.D.

Blood (2007) 110 (11): 4402.

https://doi.org/10.1182/blood.V110.11.4402.4402

Published: 2007

Journal Articles

Phase-2 Study of R-MACLO-IVAM-T in Newly Diagnosed Mantle Cell Lymphoma.

Izidore S. Lossos, MD, Francine Colleman, Gail Walker, Maricer Escalon, MD, Joseph Rosenblatt, MD, Daniel Morgensztern, MD

Blood (2007) 110 (11): 1363.

https://doi.org/10.1182/blood.V110.11.1363.1363

Published: 2007

NARROW

Incidence and Outcomes for Low Risk Myelodysplastic Syndrome: A Surveillance, Epidemiology and End Results (SEER) Study

Waldenstrom's Macroglobulinemia: A SEER Database Review From 1981-2005.

High Remission Rates and Prolonged Progression Free Survival in Newly Diagnosed Patients with Mantle Cell Lymphoma Treated with R-MACLOIVAM-T

Lack of Survival Improvement in Patients with Large Cell Lymphomas of T-Cell Phenotype: A SEER Analysis Comparing Outcomes According to Phenotype and Year of Diagnosis.

Primary Non-Hodgkin’s Lymphoma of the Lung.

Phase-2 Study of R-MACLO-IVAM-T in Newly Diagnosed Mantle Cell Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Incidence and Outcomes for Low Risk Myelodysplastic Syndrome: A Surveillance, Epidemiology and End Results (SEER) Study

Waldenstrom's Macroglobulinemia: A SEER Database Review From 1981-2005.

High Remission Rates and Prolonged Progression Free Survival in Newly Diagnosed Patients with Mantle Cell Lymphoma Treated with R-MACLOIVAM-T

Lack of Survival Improvement in Patients with Large Cell Lymphomas of T-Cell Phenotype: A SEER Analysis Comparing Outcomes According to Phenotype and Year of Diagnosis.

Primary Non-Hodgkin’s Lymphoma of the Lung.

Phase-2 Study of R-MACLO-IVAM-T in Newly Diagnosed Mantle Cell Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only